HomeSZLS • TSE
add
StageZero Life Sciences Ltd
Previous close
$0.040
Year range
$0.035 - $0.075
Market cap
4.92M CAD
Avg Volume
72.52K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | 745.49K | -6.74% |
Operating expense | 929.15K | -39.21% |
Net income | -821.88K | -1,722.52% |
Net profit margin | -110.25 | -1,854.79% |
Earnings per share | — | — |
EBITDA | -722.64K | 40.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.09K | -27.55% |
Total assets | 508.42K | -93.95% |
Total liabilities | 9.58M | 37.14% |
Total equity | -9.07M | — |
Shares outstanding | 123.55M | — |
Price to book | -0.57 | — |
Return on assets | -294.19% | — |
Return on capital | 25.97% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -821.88K | -1,722.52% |
Cash from operations | 47.82K | 167.28% |
Cash from investing | — | — |
Cash from financing | -87.93K | -177.34% |
Net change in cash | -40.11K | -194.11% |
Free cash flow | 385.22K | 335.52% |
About
Founded
1997
Headquarters
Website
Employees
40
